Genflow Biosciences plc
Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducin… Read more
Genflow Biosciences plc (GENFF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.246x
Based on the latest financial reports, Genflow Biosciences plc (GENFF) has a cash flow conversion efficiency ratio of -0.246x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-422.10K) by net assets ($1.72 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genflow Biosciences plc - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Genflow Biosciences plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genflow Biosciences plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genflow Biosciences plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anmol India Limited
NSE:ANMOL
|
0.002x |
|
WINMARK
BE:GBZ
|
-0.359x |
|
Sunrise Real Estate Group Inc
PINK:SRRE
|
0.038x |
|
AI Unlimited Group, Inc.
OTCQB:AIUG
|
-1.384x |
|
EDM Resources Inc
PINK:SWNLF
|
-0.028x |
|
LABEL VIE
BC:LABEL-VIE
|
N/A |
|
Kiang Huat Sea Gull Trading Frozen Food Public Company Limited
BK:CHOTI
|
-0.105x |
|
International Network System PCL
BK:ITNS
|
0.003x |
Annual Cash Flow Conversion Efficiency for Genflow Biosciences plc (2021–2024)
The table below shows the annual cash flow conversion efficiency of Genflow Biosciences plc from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-403.01K | $-1.08 Million | 2.685x | +180.80% |
| 2023-12-31 | $499.69K | $-1.66 Million | -3.324x | -474.62% |
| 2022-12-31 | $2.37 Million | $-1.37 Million | -0.578x | +96.09% |
| 2021-12-31 | $55.12K | $-815.32K | -14.791x | -- |